시장보고서
상품코드
1957639

의약품 단위 용량 포장 시장 보고서(2026년)

Pharmaceutical Unit-Dose Packaging Global Market Report 2026

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

의약품 단위 용량 포장 시장 규모는 최근 급성장하고 있습니다. 2025년 545억 달러에서 2026년에는 607억 9,000만 달러에 이르고, CAGR 11.6%의 성장이 전망되고 있습니다. 지난 몇 년간의 성장은 병원의 약물 안전 조치 강화, 정확한 약물 용량에 대한 수요 증가, 주사제 및 생물학적 제제 요법의 확대, 외래 진료 환경의 성장, 의약품 포장 재료의 발전에 기인하는 것으로 보입니다.

의약품 단위 용량 포장 시장 규모는 향후 몇 년간 급성장이 전망됩니다. 2030년에는 930억 7,000만 달러에 이르고, CAGR은 11.2%를 나타낼 전망입니다. 예측 기간 동안의 성장은 스마트 포장 기술 채택 확대, 환자 중심 약물 투여에 대한 관심 증가, 생물학적 제제 및 특수 의약품의 확대, 컴플라이언스 대응 포장에 대한 수요 증가, 의약품 포장 라인의 자동화 발전 등에 기인할 것으로 보입니다. 예측 기간의 주요 동향으로는 1회용 안전포장 채택 확대, 블리스 터 포장 및 프리필드시린지 형태 수요 증가, 추적 기술 도입 확대, 고차단성 포장재 보급, 약물 오투약 감소에 대한 집중도 강화 등이 있습니다.

예방접종 프로그램 및 예방접종 캠페인의 확대는 향후 몇 년 동안 의약품 1회용 포장 시장의 성장을 견인할 것으로 예측됩니다. 예방접종 프로그램 및 예방접종 캠페인은 백신을 체계적으로 투여하여 감염성 질환으로부터 인구를 보호하는 것을 목표로 하는 체계적인 공중보건 대책입니다. 이러한 프로그램 및 캠페인의 확대는 전염병 발생 빈도가 증가함에 따라 정부와 보건 기관이 감염 예방 조치를 강화하고 공중 보건을 보호해야 할 필요성을 촉구하고 있습니다. 의약품 1회용 포장은 정확한 복용량 보장, 약물 오남용 최소화, 무균성 유지, 대규모 백신 접종 활동에서 배포 및 투여를 용이하게 함으로써 예방접종 프로그램 및 백신 접종 캠페인을 지원합니다. 예를 들어, 영국 정부 기관인 영국 보건안전청(UK Health Security Agency)에 따르면, 2023년 6월 기준, 2022-2023학년도에 총 3,502,566명의 아동 및 학생이 학령기 백신 접종 프로그램에 참여하여 접종을 받았습니다. 이는 2021-2022년 동 연령대 3,615,536명과 비교한 수치입니다. 이처럼 예방접종 프로그램 및 백신 접종 캠페인의 확대가 의약품 1회용 포장 시장의 성장을 견인하고 있습니다.

의약품 1회용 포장 시장에서 사업을 전개하고 있는 주요 기업들은 투약 정확도 향상과 병원 및 약국의 업무 효율화를 위해 무균 1회용 제네릭 의약품 등 첨단 솔루션 개발에 주력하고 있습니다. 무균 1회용 제네릭 의약품은 미생물 오염 없이 안전하고 정확한 투여를 보장하는 사전 계량 및 개별 포장된 의약품으로, 브랜드 의약품의 무균 의약품을 대체할 수 있는 비용 효율적인 대안을 제시합니다. 예를 들어, 2023년 8월 미국 제약회사 Ritedose Pharmaceuticals는 크로모린 나트륨 흡입액 USP(20mg/2ml)를 발표했습니다. 천식 예방 관리를 위한 흡입용 항염증제 역할을 하는 이 새로운 무균 1회용 제네릭 의약품은 60개의 1회용 바이알이 한 상자에 들어있는 형태로 제공됩니다. 이로써 리테도스의 흡입용액 제품 라인이 확대되어 본 약제를 정기적으로 필요로 하는 고객에게 안정적으로 공급할 수 있게 되었습니다.

자주 묻는 질문

  • 의약품 단위 용량 포장 시장 규모는 어떻게 변화하고 있나요?
  • 의약품 단위 용량 포장 시장의 성장 요인은 무엇인가요?
  • 예방접종 프로그램의 확대가 의약품 1회용 포장 시장에 미치는 영향은 무엇인가요?
  • 의약품 1회용 포장 시장에서 주요 기업들은 어떤 방향으로 사업을 전개하고 있나요?
  • 무균 1회용 제네릭 의약품의 특징은 무엇인가요?

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병(M&A)

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

LSH 26.03.16

Pharmaceutical unit-dose packaging involves packaging medication in individual, pre-measured containers. Its primary purpose is to provide accurate dosing, reduce medication errors, and improve patient safety. It also helps preserve drug stability, extend shelf life, and enables easy handling and administration in hospitals, pharmacies, and home care settings.

The primary product types in pharmaceutical unit-dose packaging include blisters, ampoules, vials, and prefilled syringes and cartridges. Blisters in pharmaceutical unit-dose packaging are sealed compartments made of plastic or aluminum that individually enclose a single tablet or capsule, providing product protection, precise dosing, and tamper evidence. They are manufactured from various materials such as plastics, glass, paper and paperboard, and metal, and are used for multiple applications, including ophthalmic, injectable, biologics, wound care, respiratory therapy, and oral.

Tariffs are impacting the pharmaceutical unit-dose packaging market by increasing costs of imported plastics, specialty glass, aluminum foils, and packaging machinery used across blisters, vials, ampoules, and prefilled syringes. North America and Europe are most affected due to reliance on imported raw materials and equipment, while Asia-Pacific faces pricing pressure on packaging exports. These tariffs are raising production costs and affecting packaging margins. However, they are also driving local material sourcing, regional packaging manufacturing expansion, and innovation in cost-efficient and sustainable unit-dose packaging solutions.

The pharmaceutical unit-dose packaging market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical unit-dose packaging market statistics, including pharmaceutical unit-dose packaging industry global market size, regional shares, competitors with a pharmaceutical unit-dose packaging market share, detailed pharmaceutical unit-dose packaging market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical unit-dose packaging industry. This pharmaceutical unit-dose packaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharmaceutical unit-dose packaging market size has grown rapidly in recent years. It will grow from $54.5 billion in 2025 to $60.79 billion in 2026 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to increasing hospital medication safety initiatives, rising demand for precise drug dosing, expansion of injectable and biologic therapies, growth of outpatient care settings, advancements in pharmaceutical packaging materials.

The pharmaceutical unit-dose packaging market size is expected to see rapid growth in the next few years. It will grow to $93.07 billion in 2030 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to increasing adoption of smart packaging technologies, rising focus on patient-centric drug delivery, expansion of biologics and specialty drugs, growing demand for compliance-ready packaging, increasing automation in pharmaceutical packaging lines. Major trends in the forecast period include increasing adoption of unit-dose safety packaging, rising demand for blister and prefilled syringe formats, growing integration of track-and-trace technologies, expansion of high-barrier packaging materials, enhanced focus on medication error reduction.

The expansion of immunization programs and vaccination campaigns is anticipated to drive the growth of the pharmaceutical unit-dose packaging market in the coming years. Immunization programs and vaccination campaigns are organized public health efforts aimed at protecting populations from infectious diseases through the systematic administration of vaccines. The growth in these programs and campaigns is fueled by the increasing occurrence of infectious disease outbreaks, prompting governments and health organizations to enhance measures to prevent transmission and safeguard public health. Pharmaceutical unit-dose packaging supports immunization programs and vaccination campaigns by ensuring precise dosing, minimizing medication errors, maintaining sterility, and facilitating distribution and administration in large-scale vaccination initiatives. For example, in June 2023, according to the UK Health Security Agency, a UK government agency, the school-aged vaccination program recorded a total of 3,502,566 children (from Reception to Year 9) vaccinated in 2022-2023, compared to 3,615,536 children in the same age group during 2021-2022. Thus, the expansion of immunization programs and vaccination campaigns is driving the growth of the pharmaceutical unit-dose packaging market.

Major companies operating in the pharmaceutical unit-dose packaging market are concentrating on creating advanced solutions such as sterile unit-dose generic products to enhance dosing accuracy and optimize hospital and pharmacy workflows. Sterile unit-dose generic products consist of pre-measured, individually packaged medications designed to be free from microbial contamination, ensuring safe and precise dosing while providing a cost-effective alternative to branded sterile drugs. For example, in August 2023, Ritedose Pharmaceuticals, a US-based pharmaceutical company, introduced a cromolyn sodium inhalation solution, USP (20 mg/2 ml). This new sterile unit-dose generic product serves as an inhaled anti-inflammatory agent for the preventive management of asthma and is provided in cartons containing 60 single-dose vials. It broadens Ritedose's range of inhalation solutions and ensures a dependable supply for clients requiring this medication regularly.

In November 2024, Safecor Health, a US-based unit-dose repackaging company, acquired the US unit-dose packaging business from Viatris Inc. for an undisclosed sum. Through this acquisition, Safecor Health intends to broaden its generic unit-dose product portfolio, improve cost efficiency, and reinforce its supply chain partnerships to deliver more comprehensive solutions to healthcare providers and manufacturers. Viatris Inc. is a US-based pharmaceutical company that provides pharmaceutical unit-dose packaging.

Major companies operating in the pharmaceutical unit-dose packaging market are Pfizer Inc., Johnson & Johnson Innovation LLC, Merck & Co. Inc., AbbVie Inc., Becton Dickinson and Company, Amcor Plc, Nipro Corporation, Aptar Group Inc., West Pharmaceutical Services Inc., Constantia Flexibles Group GmbH, Klockner Pentaplast, Stevanato Group S.p.A., SGD SA, SP Group, Jones Healthcare Group, Innovative Pharmacy Packaging Corporation Inc., Medical Packaging Inc. LLC, Adelphi Healthcare Packaging, Sonic Packaging Industries, Alfipa, Unit Pack Company Inc.

North America was the largest region in the pharmaceutical unit-dose packaging market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical unit-dose packaging market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharmaceutical unit-dose packaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmaceutical unit-dose packaging market consists of sales of products such as unit-dose pouches, sachets, strip packs, stick packs, prefilled droppers, nasal spray units, and ophthalmic single-dose containers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Unit-Dose Packaging Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses pharmaceutical unit-dose packaging market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical unit-dose packaging ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pharmaceutical unit-dose packaging market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Blisters; Ampoules; Vials; Prefilled Syringes And Cartridges
  • 2) By Material: Plastics; Glass; Paper And Paperboard; Metal
  • 3) By End-Use: Ophthalmic; Injectable; Biologics; Wound Care; Respiratory Therapy; Orals
  • Subsegments:
  • 1) By Blisters: Push-Through Blisters; Peelable Blisters; Cold Formed Blisters; Thermoformed Blisters
  • 2) By Ampoules: Open Ampoules; Closed Ampoules; Flame-Sealed Ampoules; Pressure-Sealed Ampoules
  • 3) By Vials: Single-Dose Vials; Multi-Dose Vials; Crimp Neck Vials; Screw Neck Vials
  • 4) By Prefilled Syringes And Cartridges: Disposable Prefilled Syringes; Reusable Prefilled Syringes; Glass Cartridges; Plastic Cartridges
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson Innovation LLC; Merck & Co. Inc.; AbbVie Inc.; Becton Dickinson and Company; Amcor Plc; Nipro Corporation; Aptar Group Inc.; West Pharmaceutical Services Inc.; Constantia Flexibles Group GmbH; Klockner Pentaplast; Stevanato Group S.p.A.; SGD SA; SP Group; Jones Healthcare Group; Innovative Pharmacy Packaging Corporation Inc.; Medical Packaging Inc. LLC; Adelphi Healthcare Packaging; Sonic Packaging Industries; Alfipa; Unit Pack Company Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Pharmaceutical Unit-Dose Packaging Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Pharmaceutical Unit-Dose Packaging Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Pharmaceutical Unit-Dose Packaging Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Pharmaceutical Unit-Dose Packaging Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Sustainability, Climate Tech & Circular Economy
    • 4.1.2 Industry 4.0 & Intelligent Manufacturing
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Artificial Intelligence & Autonomous Intelligence
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Unit-Dose Safety Packaging
    • 4.2.2 Rising Demand For Blister And Prefilled Syringe Formats
    • 4.2.3 Growing Integration Of Track-And-Trace Technologies
    • 4.2.4 Expansion Of High-Barrier Packaging Materials
    • 4.2.5 Enhanced Focus On Medication Error Reduction

5. Pharmaceutical Unit-Dose Packaging Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Pharmacies
  • 5.3 Pharmaceutical Manufacturers
  • 5.4 Home Healthcare Providers
  • 5.5 Contract Packaging Organizations

6. Pharmaceutical Unit-Dose Packaging Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Pharmaceutical Unit-Dose Packaging Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Pharmaceutical Unit-Dose Packaging PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Pharmaceutical Unit-Dose Packaging Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Pharmaceutical Unit-Dose Packaging Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Pharmaceutical Unit-Dose Packaging Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Pharmaceutical Unit-Dose Packaging Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Pharmaceutical Unit-Dose Packaging Market Segmentation

  • 9.1. Global Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Blisters, Ampoules, Vials, Prefilled Syringes And Cartridges
  • 9.2. Global Pharmaceutical Unit-Dose Packaging Market, Segmentation By Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Plastics, Glass, Paper And Paperboard, Metal
  • 9.3. Global Pharmaceutical Unit-Dose Packaging Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Ophthalmic, Injectable, Biologics, Wound Care, Respiratory Therapy, Orals
  • 9.4. Global Pharmaceutical Unit-Dose Packaging Market, Sub-Segmentation Of Blisters, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Push-Through Blisters, Peelable Blisters, Cold Formed Blisters, Thermoformed Blisters
  • 9.5. Global Pharmaceutical Unit-Dose Packaging Market, Sub-Segmentation Of Ampoules, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Open Ampoules, Closed Ampoules, Flame-Sealed Ampoules, Pressure-Sealed Ampoules
  • 9.6. Global Pharmaceutical Unit-Dose Packaging Market, Sub-Segmentation Of Vials, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Single-Dose Vials, Multi-Dose Vials, Crimp Neck Vials, Screw Neck Vials
  • 9.7. Global Pharmaceutical Unit-Dose Packaging Market, Sub-Segmentation Of Prefilled Syringes And Cartridges, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Disposable Prefilled Syringes, Reusable Prefilled Syringes, Glass Cartridges, Plastic Cartridges

10. Pharmaceutical Unit-Dose Packaging Market Regional And Country Analysis

  • 10.1. Global Pharmaceutical Unit-Dose Packaging Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Pharmaceutical Unit-Dose Packaging Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Pharmaceutical Unit-Dose Packaging Market

  • 11.1. Asia-Pacific Pharmaceutical Unit-Dose Packaging Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Pharmaceutical Unit-Dose Packaging Market

  • 12.1. China Pharmaceutical Unit-Dose Packaging Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Pharmaceutical Unit-Dose Packaging Market

  • 13.1. India Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Pharmaceutical Unit-Dose Packaging Market

  • 14.1. Japan Pharmaceutical Unit-Dose Packaging Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Pharmaceutical Unit-Dose Packaging Market

  • 15.1. Australia Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Pharmaceutical Unit-Dose Packaging Market

  • 16.1. Indonesia Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Pharmaceutical Unit-Dose Packaging Market

  • 17.1. South Korea Pharmaceutical Unit-Dose Packaging Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Pharmaceutical Unit-Dose Packaging Market

  • 18.1. Taiwan Pharmaceutical Unit-Dose Packaging Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Pharmaceutical Unit-Dose Packaging Market

  • 19.1. South East Asia Pharmaceutical Unit-Dose Packaging Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Pharmaceutical Unit-Dose Packaging Market

  • 20.1. Western Europe Pharmaceutical Unit-Dose Packaging Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Pharmaceutical Unit-Dose Packaging Market

  • 21.1. UK Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Pharmaceutical Unit-Dose Packaging Market

  • 22.1. Germany Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Pharmaceutical Unit-Dose Packaging Market

  • 23.1. France Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Pharmaceutical Unit-Dose Packaging Market

  • 24.1. Italy Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Pharmaceutical Unit-Dose Packaging Market

  • 25.1. Spain Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Pharmaceutical Unit-Dose Packaging Market

  • 26.1. Eastern Europe Pharmaceutical Unit-Dose Packaging Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Pharmaceutical Unit-Dose Packaging Market

  • 27.1. Russia Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Pharmaceutical Unit-Dose Packaging Market

  • 28.1. North America Pharmaceutical Unit-Dose Packaging Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Pharmaceutical Unit-Dose Packaging Market

  • 29.1. USA Pharmaceutical Unit-Dose Packaging Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Pharmaceutical Unit-Dose Packaging Market

  • 30.1. Canada Pharmaceutical Unit-Dose Packaging Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Pharmaceutical Unit-Dose Packaging Market

  • 31.1. South America Pharmaceutical Unit-Dose Packaging Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Pharmaceutical Unit-Dose Packaging Market

  • 32.1. Brazil Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Pharmaceutical Unit-Dose Packaging Market

  • 33.1. Middle East Pharmaceutical Unit-Dose Packaging Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Pharmaceutical Unit-Dose Packaging Market

  • 34.1. Africa Pharmaceutical Unit-Dose Packaging Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Pharmaceutical Unit-Dose Packaging Market Regulatory and Investment Landscape

36. Pharmaceutical Unit-Dose Packaging Market Competitive Landscape And Company Profiles

  • 36.1. Pharmaceutical Unit-Dose Packaging Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Pharmaceutical Unit-Dose Packaging Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Pharmaceutical Unit-Dose Packaging Market Company Profiles
    • 36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Johnson & Johnson Innovation LLC Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

37. Pharmaceutical Unit-Dose Packaging Market Other Major And Innovative Companies

  • Amcor Plc, Nipro Corporation, Aptar Group Inc., West Pharmaceutical Services Inc., Constantia Flexibles Group GmbH, Klockner Pentaplast, Stevanato Group S.p.A., SGD SA, SP Group, Jones Healthcare Group, Innovative Pharmacy Packaging Corporation Inc., Medical Packaging Inc. LLC, Adelphi Healthcare Packaging, Sonic Packaging Industries, Alfipa

38. Global Pharmaceutical Unit-Dose Packaging Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Pharmaceutical Unit-Dose Packaging Market

40. Pharmaceutical Unit-Dose Packaging Market High Potential Countries, Segments and Strategies

  • 40.1 Pharmaceutical Unit-Dose Packaging Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Pharmaceutical Unit-Dose Packaging Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Pharmaceutical Unit-Dose Packaging Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제